Baltimore, United States. The U.S. government was in charge of a power plant where Johnson & Johnson destroyed its COVID-19 vaccine dose of 15 million, and British drugmaker Astroseneca PLC prevented it from using the facility.
J&J said it was taking full responsibility for Baltimore’s emergency bio-solution facility, and reiterated that the government would provide 100 million doses by the end of May.
The health official said in an email that the Department of Health and Human Services would facilitate the change, and asked not to be named because of the sensitivity of the matter.
Astraseneka, who has not approved the vaccine in the United States, said it was working with the presidential government Joe Biden To find an alternative place to manufacture your vaccine.
Earlier in the week, the New York Times reported that workers at the emergency biological solutions factory had mixed the ingredients in the J&J and AstraZeneca vaccines a few weeks earlier. J&J then said that the spoiled team had not progressed to the filling and finishing stage.
The U.S. newspaper quoted two federal health officials as saying that the government’s move to produce only a single dose of J&J vaccine aims to avoid future confusion.
America’s top infectious disease doctor said on Thursday that the country does not need the AstraZeneca vaccine even if it is approved.
The U.S. has agreements to ship about 4 million doses of the AstraZeneca vaccine, manufactured at U.S. facilities, to Mexico and Canada.
Johnson & Johnson, a subcontractor, was working to produce two biological solutions, Johnson & Johnson and AstraZeneca. But somehow they mixed the two ingredients and they destroyed 15 million doses.
Biden’s response was to control the factory from emergency biological solutions. From here, the plant produces only one vaccine: Johnson & Johnson.
The recession comes at a bad time for the Biden administration, which has promised to vaccinate all Americans by the end of May. Johnson & Johnson, which produces the only licensed single-dose vaccine, is a critical part of that effort.
The administration has asked Johnson & Johnson to produce 100 million doses by the end of May.
According to The Independent, emergency biological solutions have a “troublesome history.” Even before the injection error, the company had already been mentioned several times by the regulatory body regarding various violations of the loan, such as poorly trained personnel, detection of fungus and mold on broken bottles and samples.
“Human error is happening,” Special Anthony Fowzie told CBS. The good news is that it will be revealed. That is why nothing produced at the plant enters the distribution chain, ”he assured.